Greenland Mines Prices $20 Million Public Offering to Fund Rare Earth Acquisition

Greenland Mines Ltd (NASDAQ: GRML) announced the pricing of a $20 million public offering, with proceeds earmarked for the acquisition of the Sarfartoq rare earth project, underscoring its strategic push into critical minerals.

Philly Metrowire Staff
Business
Greenland Mines Prices $20 Million Public Offering to Fund Rare Earth Acquisition

Greenland Mines Ltd (NASDAQ: GRML) has announced the pricing of its previously announced public offering, which is expected to generate approximately $20 million in aggregate gross proceeds before placement agent fees and other offering expenses. The offering covers 4 million shares of common stock, or common stock equivalents, to new and existing mining-focused institutional investors. The transaction is expected to close on or about Aug. 27, 2026, subject to customary closing conditions.

The net proceeds from the offering are intended to fund the acquisition of the Sarfartoq Nd-Pr Rare Earth Element Project, working capital, and other general corporate purposes. This move underscores Greenland Mines' strategic focus on expanding its footprint in the critical minerals sector, particularly in rare earth elements essential for modern technologies such as electric vehicles, wind turbines, and advanced electronics.

The Sarfartoq project, located in southwest Greenland, is a significant neodymium-praseodymium (Nd-Pr) rare earths deposit. Nd-Pr are crucial components in permanent magnets used in various high-tech applications, and securing a domestic source of these materials is a priority for Western nations aiming to reduce dependence on Chinese supply chains. By acquiring this project, Greenland Mines positions itself to capitalize on the growing demand for rare earth elements.

The company operates with two divisions: Mining and Biotech. The Mining division focuses on the exploration and development of the Skaergaard Project in southeast Greenland, along with the Sarfartoq project, subject to closing. The Biotech division includes Klotho’s KLTO‑202, which targets ALS as its primary indication. This diversified approach allows Greenland Mines to balance its resource development with potential breakthroughs in biotechnology.

Greenland Mines' strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals, and selected midstream processing opportunities. The company is also advancing its broader North Atlantic Critical Metals Corridor vision, which aims to link Greenland resources with allied downstream jurisdictions and industrial infrastructure. This vision aligns with geopolitical efforts to secure critical mineral supply chains within friendly nations.

The offering is led by A.G.P./Alliance Global Partners as the sole placement agent. Investors interested in the offering should consider the potential of the Sarfartoq project and the company's broader strategic initiatives. The successful completion of this offering will provide Greenland Mines with the necessary capital to advance its rare earth ambitions.

For more details on the offering and the company's plans, visit the full press release at https://ibn.fm/iMYIM. For the latest news and updates on Greenland Mines, visit the company's newsroom at https://ibn.fm/GRML.

Blockchain Registration

QR Code for Blockchain Registration